Samsara Bio Capital, LLC Lyra Therapeutics, Inc. Transaction History
Samsara Bio Capital, LLC
- $173 Million
- Q3 2024
A detailed history of Samsara Bio Capital, LLC transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 2,780,261 shares of LYRA stock, worth $500,446. This represents 0.42% of its overall portfolio holdings.
Number of Shares
2,780,261
Previous 2,780,261
-0.0%
Holding current value
$500,446
Previous $778,000
7.2%
% of portfolio
0.42%
Previous 0.4%
Shares
3 transactions
Others Institutions Holding LYRA
# of Institutions
62Shares Held
32.2MCall Options Held
21.1KPut Options Held
400-
Perceptive Advisors LLC New York, NY12.8MShares$2.3 Million0.09% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.77MShares$859,1060.0% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$509,3960.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.78MShares$320,2670.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$190,2290.05% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $5.73M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...